LMAX
Hamilton Healthcare Yield Maximizer ETF

Full LMAX fund page
VS

Suggested funds:

Select a second ETF to benchmark against Hamilton Healthcare Yield Maximizer ETF (LMAX). Compare key metrics including year-to-date performance, management fees, sector exposures and underlying assets to ensure you are selecting the best fund for your investment objectives.

NAV Performance and Flows

-3.0-2.0-1.00.01.02.0%Aug 11Aug 18Aug 25Sep 1Sep 9

Key Data

Historical performance and flows

As of September 11, 2026
1M3MYTD1Y3Y
Perf.
LMAX
-2.67%+5.23%+4.27%+12.64%-
Flows
LMAX
+$5 M+$16 M+$71 M+$84 M-

Exposure

Countries

LMAX
USA
95.96%

Sectors

LMAX
Healthcare
94.79%
As of September 11, 2026

Top 10 Holdings

LMAX
AbbVie, Inc.
5.92%
CVS Health Corp.
5.89%
UnitedHealth Group, Inc.
5.86%
Eli Lilly & Co.
5.77%
Thermo Fisher Scientific, Inc.
5.75%
Bristol Myers Squibb Co.
5.50%
Amgen, Inc.
5.25%
Johnson & Johnson
5.21%
Merck & Co., Inc.
5.20%
Abbott Laboratories
5.09%

Diversification

LMAX
Total weight of top 10 holdings out of 20 total
55.45%

Characteristics

Compare
LMAX
ProviderHamilton ETFs
ManagementActively managed
Benchmark-
Replication Method
Asset ClassEquity
Dividend PolicyDistributing
Trailing 12m distribution yield12.56%
Meets ESG criteriaNo
Inception DateFebruary 6, 2024

Recent articles about LMAX

CboeTrackinsight
The ETF Market Canada is brought to you by Cboe in partnership with Trackinsight SA who is providing all the data, analysis and editorial content on this site. Unless explicitly stated as such, any information that you receive is not real-time.

All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
diamonds